{
    "clinical_study": {
        "@rank": "9947", 
        "brief_summary": {
            "textblock": "Detection of mutation  / specific polymorphism of the EVER/TMC6 and/or EVER/TMC8 gen.\n\n      correlation between possibly detected mutation/specific polymorphism and kind and number of\n      neoplasm, age of patients, UV burden, duration and kind of immunosuppression."
        }, 
        "brief_title": "EVER(Epidermodysplasia Verruciformis Levandowsky-Lutz)/TMC(TransMembral Channel Like Protein) Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients", 
        "condition": [
            "Immunosuppression", 
            "Neoplasm"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Carcinoma", 
                "Epidermodysplasia Verruciformis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients in an immunosuppressive condition either by immunosuppressants or by HIV\n             infection\n\n        Exclusion Criteria:\n\n          -  written informed consent not given"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "patients who underwent organ transplatation or patients who have a HIV infection"
            }
        }, 
        "enrollment": {
            "#text": "377", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01942005", 
            "org_study_id": "11/10"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 9, 2013", 
        "location": {
            "contact": {
                "email": "andreas.arnold@usb.ch", 
                "last_name": "Andreas Arnold, MD", 
                "phone": "+41 61 328 67 69"
            }, 
            "facility": {
                "address": {
                    "city": "Basel", 
                    "country": "Switzerland", 
                    "state": "Basel Stadt", 
                    "zip": "4031"
                }, 
                "name": "University Hospital Basel, Dermatology"
            }, 
            "investigator": {
                "last_name": "Andreas Arnold, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_groups": "1", 
        "official_title": "EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients,Especially Patients After Organ Transplantation and Patients With HIV Infection", 
        "overall_contact": {
            "email": "andreas.arnold@usb.ch", 
            "last_name": "Andreas Arnold, MD", 
            "phone": "+41 61 328 67 69"
        }, 
        "overall_official": {
            "affiliation": "University Hospital Basel, Dermatology, CH-4031 Basel", 
            "last_name": "Andreas Arnold, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Ethikkommission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Detection of mutation / specific polymorphism of the EVER/TMC6 and/or EVER/TMC8 gen.", 
            "safety_issue": "No", 
            "time_frame": "7 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01942005"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital, Basel, Switzerland", 
            "investigator_full_name": "Andreas Arnold", 
            "investigator_title": "Dr. med. Andreas Arnold, senior physician", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "correlation between possibly detected mutation/specific polymorphism of the EVER/TMC6 and/or EVER/TMC8 gen and a composite of kind and number of neoplasm, age of patients, UV burden, duration and kind of immunosuppression.", 
            "safety_issue": "No", 
            "time_frame": "7 years"
        }, 
        "source": "University Hospital, Basel, Switzerland", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Andreas Arnold", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2010", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "September 2013"
    }
}